Primary penile melanoma and genital lichen sclerosus.


Journal

Skin health and disease
ISSN: 2690-442X
Titre abrégé: Skin Health Dis
Pays: England
ID NLM: 9918227353706676

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 02 02 2023
revised: 17 07 2023
accepted: 28 07 2023
medline: 4 12 2023
pubmed: 4 12 2023
entrez: 4 12 2023
Statut: epublish

Résumé

There is a well-established association between squamous cell cancer and genital lichen sclerosus (GLSc). Although there have been several reported cases of vulval melanoma (MM) associated with LSc, particularly in the paediatric population, fewer cases of male genital (M) GLSc and penile (Pe)MM have been published. The aim of this study was to explore further the relationship between PeMM and MGLSc by reviewing all the cases managed by our multidisciplinary service over a finite period. All patients known to our tertiary urology and male genital dermatology service with a diagnosis of PeMM and where histology was available for review were identified over an 11-year period (2011-2022). The histology was reviewed by two independent, mutually 'blinded' histopathologists. Photographs and clinical notes, where available, were retrospectively reviewed by two independent dermatologists for signs or symptoms of LSc. Eleven patients with PeMM were identified for review. Histopathological examination found evidence of LSc in nine patients, and review of clinical photos corroborated the presence of LSc in three. Overall, features of LSc were present in nine out of eleven cases (82%). The presence of LSc in 9 out of 11 cases of PeMM is suggestive of a causative relationship between LSc and PeMM. This may be due to chronic melanocytic distress created by chronic inflammation secondary to LSc.

Sections du résumé

Background UNASSIGNED
There is a well-established association between squamous cell cancer and genital lichen sclerosus (GLSc). Although there have been several reported cases of vulval melanoma (MM) associated with LSc, particularly in the paediatric population, fewer cases of male genital (M) GLSc and penile (Pe)MM have been published.
Objectives UNASSIGNED
The aim of this study was to explore further the relationship between PeMM and MGLSc by reviewing all the cases managed by our multidisciplinary service over a finite period.
Methods UNASSIGNED
All patients known to our tertiary urology and male genital dermatology service with a diagnosis of PeMM and where histology was available for review were identified over an 11-year period (2011-2022). The histology was reviewed by two independent, mutually 'blinded' histopathologists. Photographs and clinical notes, where available, were retrospectively reviewed by two independent dermatologists for signs or symptoms of LSc.
Results UNASSIGNED
Eleven patients with PeMM were identified for review. Histopathological examination found evidence of LSc in nine patients, and review of clinical photos corroborated the presence of LSc in three. Overall, features of LSc were present in nine out of eleven cases (82%).
Conclusion UNASSIGNED
The presence of LSc in 9 out of 11 cases of PeMM is suggestive of a causative relationship between LSc and PeMM. This may be due to chronic melanocytic distress created by chronic inflammation secondary to LSc.

Identifiants

pubmed: 38047263
doi: 10.1002/ski2.274
pii: SKI2274
pmc: PMC10690690
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e274

Informations de copyright

© 2023 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

Déclaration de conflit d'intérêts

None to declare.

Références

Sex Transm Infect. 2001 Jun;77(3):226
pubmed: 11402247
Am J Dermatopathol. 2007 Feb;29(1):13-7
pubmed: 17284956
J Am Acad Dermatol. 2004 May;50(5):690-4
pubmed: 15097951
JAMA Dermatol. 2016 Feb;152(2):226-7
pubmed: 26536280
J Dermatolog Treat. 2022 Mar;33(2):1047-1062
pubmed: 32705920
J Eur Acad Dermatol Venereol. 2018 Jan;32(1):91-95
pubmed: 28750140
Scand J Urol Nephrol Suppl. 2000;(205):201-14
pubmed: 11144899
South Med J. 2003 Jan;96(1):9-11
pubmed: 12602705
Br J Dermatol. 2009 Dec;161(6):1225-31
pubmed: 19785608
Int J Mol Sci. 2020 Jul 09;21(14):
pubmed: 32659938
Br J Dermatol. 2007 Nov;157(5):1079-80
pubmed: 17854373
Indian J Dermatol. 2015 Mar-Apr;60(2):111-7
pubmed: 25814697
J Am Acad Dermatol. 2006 Feb;54(2 Suppl):S52-3
pubmed: 16427997
Semin Diagn Pathol. 2021 Jan;38(1):99-109
pubmed: 32943238
J Urol. 2005 Jun;173(6):1958-65
pubmed: 15879790
Arch Dermatol. 2002 Jan;138(1):77-87
pubmed: 11790170
JAAD Case Rep. 2020 Mar 25;6(4):323-325
pubmed: 32258310
Scand J Urol Nephrol. 1997 Oct;31(5):453-6
pubmed: 9406306
J Eur Acad Dermatol Venereol. 2012 Jun;26(6):730-7
pubmed: 21707769
Biomedicines. 2021 Jun 30;9(7):
pubmed: 34209084
Acta Derm Venereol. 2019 Mar 1;99(3):339-340
pubmed: 30521058
PLoS One. 2015 Apr 22;10(4):e0124395
pubmed: 25901368
Pediatr Dermatol. 2004 Jul-Aug;21(4):473-6
pubmed: 15283794
J Urol. 2006 Apr;175(4):1359-63
pubmed: 16515998
J Urol. 2011 Feb;185(2):522-5
pubmed: 21168879
J Am Acad Dermatol. 2017 Feb;76(2S1):S49-S51
pubmed: 28087029
Am J Clin Dermatol. 2020 Apr;21(2):285-295
pubmed: 31784896
J Am Acad Dermatol. 1999 Dec;41(6):911-4
pubmed: 10570372
Pigment Cell Melanoma Res. 2013 May;26(3):426-8
pubmed: 23311654
Trans St Johns Hosp Dermatol Soc. 1971;57(1):9-30
pubmed: 5570266
Skin Health Dis. 2023 Aug 12;3(6):e274
pubmed: 38047263
Skin Health Dis. 2022 Dec 11;3(2):e198
pubmed: 37013116
Am J Dermatopathol. 1984 Summer;6 Suppl:253-6
pubmed: 6528925

Auteurs

Kate Dear (K)

Department of Dermatology University College London Hospitals NHS Foundation Trust London UK.

Georgios Kravvas (G)

Department of Dermatology University College London Hospitals NHS Foundation Trust London UK.

Sharmaine Sim (S)

University College London Medical School London UK.

Evanthia Mastoraki (E)

Department of Dermatology University College London Hospitals NHS Foundation Trust London UK.

Mariel James (M)

Department of Dermatology University College London Hospitals NHS Foundation Trust London UK.

Richard Watchorn (R)

Department of Dermatology University College London Hospitals NHS Foundation Trust London UK.

Aiman Haider (A)

Department of Histopathology University College London Hospitals NHS Foundation Trust London UK.

Peter Ellery (P)

Department of Histopathology University College London Hospitals NHS Foundation Trust London UK.

Alex Freeman (A)

Department of Histopathology University College London Hospitals NHS Foundation Trust London UK.

Hussain M Alnajjar (HM)

Department of Urology University College London Hospitals NHS Foundation Trust London UK.

Asif Muneer (A)

Department of Urology University College London Hospitals NHS Foundation Trust London UK.

Christopher B Bunker (CB)

Department of Dermatology University College London Hospitals NHS Foundation Trust London UK.

Classifications MeSH